Gema Moreno-Bueno

Full Professor

Universidad Autónoma de Madrid

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Cancer Biology Cancer Biology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Gema Moreno-Bueno is a Full Professor at Universidad Autonoma Madrid, Spain. Her research focuses on cancer biology, particularly in the areas of antibacterial defense mechanisms, inflammatory diseases, and therapeutic resistance in various tumors. Recent publications highlight significant findings in breast cancer dynamics, tumor microenvironment components, and advancements in treatment strategies.

Articles (15)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (11)

Francisco Hermida-Prado

University of Oviedo

SPAIN

View details

Anna Pujol

Head of Transgenic Animal Unit - Associated Teacher

Universitat Autònoma de Barcelona

SPAIN

View details

Sandra Blasco Benito

Hospital del Mar

SPAIN

View details

Patricia Mondelo-Macía

SPAIN

View details

Maria Efigenia Arias

Associate Professor (P6)

Universidade de Santiago de Compostela

SPAIN

View details

Alicja Rajtak

Medical University of Lublin

POLAND

View details

José Palacios

SPAIN

View details

Juana M. García-Pedrero

University of Oviedo

SPAIN

View details

RUBEN FERNANDEZ DE LA ROSA

Universidad Complutense de Madrid

SPAIN

View details

Alba Ferreirós

Profesora asociada

Universidade de Santiago de Compostela

SPAIN

View details

Eduardo Perez-gomez

Associate Professor

Universidad Complutense de Madrid

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gema Moreno-Bueno

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Fatty acid amide hydrolase drives adult mammary gland development by promoting luminal cell differentiation

Gasdermin‐B (GSDMB) takes center stage in antibacterial defense, inflammatory diseases, and cancer

TPX2 overexpression promotes sensitivity to dasatinib in breast cancer by activating YAP transcriptional signaling

HuR (ELAVL1) Stabilizes SOX9 mRNA and Promotes Migration and Invasion in Breast Cancer Cells

The E1a Adenoviral Gene Upregulates the Yamanaka Factors to Induce Partial Cellular Reprogramming

Evaluation of ERBB2 mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases

Scientific and clinical relevance of non-cellular tumor microenvironment components in ovarian cancer chemotherapy resistance.

Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted Drugs

Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival

Clinical validation of a novel quantitative assay for the detection of MGMT methylation in glioblastoma patients

E2A Modulates Stemness, Metastasis, and Therapeutic Resistance of Breast Cancer

Impact of notch signaling on the prognosis of patients with head and neck squamous cell carcinoma

Insight updating of the molecular hallmarks in ovarian carcinoma

Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer

Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer

Collaborators (11)

Francisco Hermida-Prado

Anna Pujol

Sandra Blasco Benito

Patricia Mondelo-Macía

Maria Efigenia Arias

Alicja Rajtak

José Palacios

Juana M. García-Pedrero

RUBEN FERNANDEZ DE LA ROSA

Alba Ferreirós

Eduardo Perez-gomez

Make your next move.